Biocat Live (2)

Day Two

Thursday, December 12

8:30 am Registration & Morning Refreshments

9:25 am Chair’s Opening Remarks

Tapping into Cross-Modality Possibilities for Biocatalysis to Inspire Drug Development

9:30 am Design of Cell-Free & Cellular Biocatalytic Cascades to Produce Modality-Agnostic Building Blocks

Synopsis

• Harnessing enzyme promiscuity and biochemical pathway design to create platform transformations

• Description of nitrogenous functional group targets spanning amines, nitro compounds and non-standard amino acids

• Engineering bacterial cell lines to prevent undesired reactions for intermediates or products

10:00 am Roundtable Discussion: Are Biocatalysis Processes Always Greener?

Synopsis

• What are some points in favour for green biocatalysis processes?

• From discovery, engineering and biocatalysis, which point of the spectrum should green and economical drug development lie?

• Why may biocatalysis not be as green as may seem?

10:35 am Minimal Regret in Protein Engineering

Synopsis

• Shortcomings of current protein engineering methods, including Directed Evolution and Rational design, and other Machine Learning methods

• How this might affect the performance and success of protein engineering campaigns

• How Exazyme ensures improved success rates

10:45 am Morning Refreshments & Networking

Contributing Towards Green Chemistry During Engineering to Accelerate Sustainable Efforts & Minimize Cost

11:30 am Merging Photochemistry & Biocatalysis Towards Making a Greener Process To Enhance Sustainable Efforts

Synopsis

• Discussing how merging two emerging technologies dramatically enhanced the overall eco-design for a complex small intermediate

• Exploiting unique and unexpected reactivity during the biotransformation to further refine the process metrics

• Optimizing engineering and identifying the potential for complex biologics to widen applications

12:00 pm Exploiting Process Development & Scale Up of an Enzymatic Dynamic Kinetic Resolution (DKR) as a Green Alternative

Synopsis

• Implementing high throughput and medium throughput experimentation to move towards scalability

• In depth media engineering to overcome limitations of ketoreductase catalyzed dynamic kinetic resolution

• Addressing scale up challenges and developing solutions to achieve robust processes

12:30 pm Simplifying Enzyme Innovation

  • Erik De Vries Senior Director Business Development Enzymes, BRAIN Biotech

Synopsis

• Bridging discovery and manufacturing gaps to deliver seamless, end-to-end enzyme solutions for API production

• Optimising biocatalytic performance by leveraging a unique metagenomics platform, MetXtra™, with AI and bioinformatics to refine enzyme discovery

• Integrating precision fermentation and advanced strain platforms to accelerate scale-up and ensure reliable, high-quality enzyme manufacturing outcomes

12:40 pm Networking Lunch

1:40 pm Case Study: Eradicating Bottlenecks of Cost & Sustainability to Optimize a Through Biocatalysis Discovery in Route Optimization

  • Yichen Tan Research Investigator, Bristol Myers Squibb

Synopsis

• Revamping an initial reaction route using biocatalysis to improve cost and sustainability

• Leveraging E-rad and K-rad ERED/KRED cascades to influence commercial routes

• Generating scaled data from batch production to streamline large-scale processes

Examining Industrialization Considerations from Discovery to Downstream Processing to Achieve Desired Large-Scale Outcomes

2:10 pm Considering End-to-End Workflow Operations to Futureproof Biocatalysis

  • Scott France Associate Principal Scientist - Biocatalysis, Merck

Synopsis

• Addressing early-stage engineering considerations to prepare for later industrialization

• Creating a robust end-to-end biocatalysis strategy to streamline operations

• Optimizing the green chemistry approach for biocatalysis to enhance sustainability and minimize spend

2:40 pm Afternoon Networking

Pin-Pointing Desired Reactivity & Structure During Discovery to Futureproof Industrialization

3:15 pm Finding New Bioreactivity for Enzymes With Industry Potential to Identify Biotransformations of Future Promise

Synopsis

• Identifying novel enzymes in academia with industrial potential to understand how to overcome the application challenge

• Pin-pointing small-scale transformations to find new reactivities with revolutionary potential

• Facilitating decision-making between exploiting existing reactivity vs identifying new reactivities to set biocatalysis up for success

3:45 pm Exploring Selective C(sp3)-H Alkylation With Engineered Carbene Transferases

  • Rudi Fasan Chair in Chemistry, University of Texas at Dallas

Synopsis

• Discussing how carbene transfer reactions represent a new class of transformations accessible via biocatalysis

• Exploring developed new engineered metalloenzymes for stereoselective functionalization of C(sp3)-H bonds via carbene transfer

• Considering applications for the late-stage functionalization of APIs and drug molecules

4:15 pm Chair’s Closing Remarks & End of Summit